Citations

Citations to this article as recorded by  

• Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS
  Carlotta Bidoli, Wenjian Yang, Seth E. Karol, Marianna Lucafò, Gabriele Stocco, Jun J. Yang
  Clinical Pharmacology & Therapeutics.2026; 119(1): 84.     CrossRef
• Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles
  Andreia S. Barros, Rute Nunes, Bruno Sarmento
  Journal of Controlled Release.2026; 389: 114466.     CrossRef
• Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients
  Asghar Ali, Khalid I. AlHussaini
  Frontiers in Microbiology.2026;[Epub]     CrossRef
• Low risk of malignancies with thiopurines in an Indian cohort of patients with Inflammatory bowel disease
  Arshdeep Singh, Vandana Midha, Ajit Sood
  Indian Journal of Gastroenterology.2025; 44(3): 390.     CrossRef
• Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease
  Tracy Coelho, Guo Cheng, Sophie Lewis, James J Ashton, Farah Barakat, Kouros C T Driscoll, Adebola E Sholeye-Bolaji, Akshay Batra, Nadeem A Afzal, Robert M Beattie, Sarah Ennis
  Inflammatory Bowel Diseases.2025; 31(2): 362.     CrossRef
• Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
  Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. A
  Saudi Journal of Gastroenterology.2025; 31(3): 107.     CrossRef
• Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
  Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, John Gubatan, Geert D’Haens
  Drugs.2025; 85(1): 67.     CrossRef
• Comparison of Effects on 6-Thioguanine Nucleotides According to Mesalazine Formulation in Pediatric Patients with Ulcerative Colitis
  Hansol Kim, Yoon Zi Kim, Seon Young Kim, Yon Ho Choe, Mi Jin Kim
  Clinical Therapeutics.2025; 47(3): 196.     CrossRef
• Thiopurine S-methyltransferase – An important intersection of drug-drug interactions in thiopurine treatment
  Dunja Urbančič, Marko Jukič, Alenka Šmid, Stanislav Gobec, Janez Jazbec, Irena Mlinarič-Raščan
  Biomedicine & Pharmacotherapy.2025; 184: 117893.     CrossRef
• Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study
  Abhirup Chatterjee, Prateek Bhatia, Saroj K Sinha, Anupam K Singh, Harshal S Mandavdhare, Jimil Shah, Vaneet Jearth, Arpit Sasani, Aravind Sekar, Minu Singh, Usha Dutta, Vishal Sharma
  Expert Review of Clinical Pharmacology.2025; 18(3): 175.     CrossRef
• Cutting Edge: A Comprehensive Guide to Colorectal Cancer Surgery in Inflammatory Bowel Diseases
  Ionut Eduard Iordache, Lucian-Flavius Herlo, Razvan Popescu, Daniel Ovidiu Costea, Luana Alexandrescu, Adrian Paul Suceveanu, Sorin Deacu, Gabriela Isabela Baltatescu, Alina Doina Nicoara, Nicoleta Leopa, Andreea Nelson Twakor, Andrei Octavian Iordache, L
  Journal of Mind and Medical Sciences.2025; 12(1): 6.     CrossRef
• Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis
  Yuan-Ting Qu, Jia-Yuan Ding, Wei Pan, Fang-Rui Liu, Ai-Lian Dong
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice
  Mila Lovrić, Kristina Dukić, Silvija Čuković-Čavka, Lana Ganoci, Nada Božina, Vladimir Trkulja
  Therapeutic Drug Monitoring.2025; 47(5): 676.     CrossRef
• Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
  Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
  Intestinal Research.2025; 23(2): 129.     CrossRef
• The fate of thiopurine metabolites after switching to low‐dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis
  Ahmed B. Bayoumy, Hedwig M. A. D'Agnolo, Nanne K. H. de Boer, Chris J. J. Mulder, Luc J. J. Derijks
  British Journal of Clinical Pharmacology.2025; 91(10): 2865.     CrossRef
• Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
  Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn, Silvio Danese, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Sun Hee Lee, Seul Gi Lee, Joon Ho Lee, Jong Min Kim, Ga Hee Park, Jimin Lee, Ju Hyun Lee, Chae Young Kim, Bruce E San
  Inflammatory Bowel Diseases.2025; 31(10): 2714.     CrossRef
• NDP52 and its emerging role in pathogenesis
  Krenare Bruqi, Flavie Strappazzon
  Cell Death & Disease.2025;[Epub]     CrossRef
• Gut microbial healing in IBD: visionary approach or evidence-based reality?
  Linda Nanni, Marco Murgiano, Chieh-En Hsu, Sheida Khalili, Giovanni Cammarota, Alfredo Papa, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso
  Expert Review of Gastroenterology & Hepatology.2025; 19(8): 833.     CrossRef
• Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited
  Ahmed B. Bayoumy, Luc J. J. Derijks, Nanne K. H. de Boer
  Therapeutic Drug Monitoring.2025;[Epub]     CrossRef
• Editorial: Evolving Trends in Ulcerative Colitis Management—Insights From the Lothian Cohort
  Shintaro Akiyama
  Alimentary Pharmacology & Therapeutics.2025; 62(7): 747.     CrossRef
• Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease
  Francesca Tavano, Orazio Palmieri, Maria Latiano, Domenica Gioffreda, Tiziana Latiano, Maria Guerra, Giuseppina Martino, Maria Rosa Valvano, Fabrizio Bossa, Francesco Perri, Anna Latiano
  International Journal of Molecular Sciences.2025; 26(16): 7860.     CrossRef
• Assessment of Azathioprine-Associated Lymphopenia Incidence Rates in Polish Children with Inflammatory Bowel Disease and Autoimmune Hepatitis: A Retrospective Study
  Katarzyna Bąk-Drabik, Anna Kaput, Anna Jarzumbek, Katarzyna Górowska-Kowolik, Agnieszka Szymlak, Agnieszka Krzywicka, Piotr Adamczyk, Jarosław Kwiecień
  Children.2025; 12(8): 1093.     CrossRef
• Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context
  Arshdeep Singh, Ajit Sood
  Indian Journal of Gastroenterology.2025;[Epub]     CrossRef
• Inflammatory bowel disease in paediatrics: Navigating the old challenges and emerging frontiers
  Mohammed Al-Beltagi, Nermin K Saeed, Prabu Kumar Chokkalingam Mani, Adel S Bediwy, Reem Elbeltagi
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Enhancing Crohn’s disease management during pregnancy: innovations in therapeutic approaches and cutting-edge monitoring practices
  Mustafa Goksu, Ozan Karadeniz, Aycan Orler, Pinar Kadirogullari
  BMC Pregnancy and Childbirth.2025;[Epub]     CrossRef
• Inflammatory Bowel Disease and Pharmacotherapeutic Treatment for Healthcare Providers: A Pedagogic Tutorial
  Charlotte Silvestre, Julien Antih, Baptiste Perrier, Lucas Fabrega, Florence Bichon, Patrick Poucheret
  Gastrointestinal Disorders.2025; 7(3): 58.     CrossRef
• Recent developments in biomarker guided therapy for Crohn’s disease
  André Bargas, Joana Torres, Bram Verstockt
  Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1241.     CrossRef
• The right drug at the right time: key to IBD success
  Davide Giuseppe Ribaldone, Giulia Valdiserra, Clelia Di Salvo, Ilaria Puxeddu, Lorenzo Bertani, Luca Antonioli
  Trends in Molecular Medicine.2025;[Epub]     CrossRef
• Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles
  Tugce Eskazan, Oguz Kagan Bakkaloglu, Murat Toruner, Haluk Tarik Kani, Bilger Cavus, Volkan Yilmaz, Nalan Gulsen Unal, Ozlen Atug, Burhan Cagcag, Mehtap Dogruel, Erkan Yilmaz, Filiz Akyuz, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, Aykut Ferhat Celik
  Journal of Clinical Medicine.2025; 14(23): 8539.     CrossRef
• Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring
  Arshdeep Singh, Arshia Bhardwaj, Harmeet Kaur, Ashutosh Bawa, Vandana Midha, Ajit Sood
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Medical Management of Inflammatory Bowel Disease
  Shahrose Rahman, Ranish K. Patel, Elisa Boden, Vassiliki Liana Tsikitis
  Surgical Clinics of North America.2024; 104(3): 657.     CrossRef
• Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study
  Arshdeep Singh, Vandana Midha, Kirandeep Kaur, Ramit Mahajan, Dharmatma Singh, Ramandeep Kaur, Aditya Kohli, Avantika Chawla, Kriti Sood, Namita Bansal, Ajit Sood
  Journal of Crohn's and Colitis.2024; 18(2): 300.     CrossRef
• Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion
  Yasunori Fukumoto, Rin Kyono, Yuka Shibukawa, Yu-ki Tanaka, Noriyuki Suzuki, Yasumitsu Ogra
  Journal of Biological Chemistry.2024; 300(2): 105599.     CrossRef
• Factors Associated with Reaching Mid-Parental Height in Patients Diagnosed with Inflammatory Bowel Disease in Childhood and Adolescent Period
  So Yoon Choi, Sujin Choi, Byung-Ho Choe, Jae Hong Park, Kwang-Hae Choi, Hae Jeong Lee, Ji Sook Park, Ji-Hyun Seo, Jae Young Kim, Hyo-Jeong Jang, Suk Jin Hong, Eun Young Kim, Yeoun Joo Lee, Ben Kang
  Gut and Liver.2024; 18(1): 106.     CrossRef
• Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial
  Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, Ramit Mahajan, Kirandeep Kaur, Yogesh Kumar Gupta, Dharmatma Singh, Namita Bansal, Ramandeep Kaur, Shivam Kalra, Omesh Goyal, Varun Mehta, Ajit Sood
  American Journal of Gastroenterology.2024; 119(7): 1365.     CrossRef
• Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis
  Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Ramandeep Kaur, Shreya Garg, Kirti Arora, Namita Bansal, Ajit Sood
  Digestive Diseases and Sciences.2024; 69(4): 1389.     CrossRef
• Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care
  Ahmed B. Bayoumy, Chris J. J. Mulder, Azhar R. Ansari, Murray L. Barclay, Tim Florin, Marianne Kiszka-Kanowitz, Luc Derijks, Vishal Sharma, Nanne K. H. de Boer
  Indian Journal of Gastroenterology.2024; 43(1): 36.     CrossRef
• The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study
  Helena Gensmyr-Singer, Mårten Werner, Pontus Karling
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing
  Ralley Prentice, Emma Flanagan, Emily Wright, Lani Prideaux, William Connell, Miles Sparrow, Peter De Cruz, Mark Lust, Winita Hardikar, Rimma Goldberg, Sara Vogrin, Kirsten Palmer, Alyson Ross, Megan Burns, Tessa Greeve, Sally Bell
  Journal of Crohn's and Colitis.2024; 18(7): 1081.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease
  Mohammad Aadil Bhat, Iqra Usman, Suneela Dhaneshwar
  Current Reviews in Clinical and Experimental Pharmacology.2024; 19(3): 234.     CrossRef
• Selecting first-line advanced therapy for ulcerative colitis: A clinical application of personalized medicine
  Mariam S. Mukhtar, Mahmoud H. Mosli
  Saudi Journal of Gastroenterology.2024; 30(3): 126.     CrossRef
• Clinical Significance of Prognostic Nutrition Index in Patients with Crohn’s Disease after Primary Bowel Resection
  Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C. Carmichael, Byung Soh Min
  Yonsei Medical Journal.2024; 65(7): 380.     CrossRef
• Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
  Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
  June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
  Gut and Liver.2024; 18(4): 667.     CrossRef
• Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
  Tracy Coelho, Guo Cheng, Fernando Vazquez Lopez, James J Ashton, Robert M Beattie, Sarah Ennis
  Inflammatory Bowel Diseases.2024; 30(10): 1928.     CrossRef
• Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases
  Aleksandra Strigáč, Miłosz Caban, Ewa Małecka-Wojciesko, Renata Talar-Wojnarowska
  Journal of Clinical Medicine.2024; 13(16): 4678.     CrossRef
• Harnessing a Safe Novel Lipid Nanoparticle: Targeted Oral Delivery to Colonic Epithelial and Macrophage Cells in a Colitis Mouse Model
  Rabeya Jafrin Mow, Michal Pawel Kuczma, Xiaodi Shi, Sridhar Mani, Didier Merlin, Chunhua Yang
  Nanomaterials.2024; 14(22): 1800.     CrossRef
• Personalization of thiopurine therapy: Current recommendations and future perspectives
  Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan
  Acta Pharmaceutica.2024; 74(3): 355.     CrossRef
• Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis
  Brigid Pinnuck, Kate D. Lynch
  Expert Opinion on Pharmacotherapy.2024; 25(13): 1835.     CrossRef
• Ulcerative colitis: molecular insights and intervention therapy
  Yuqing Liang, Yang Li, Chehao Lee, Ziwei Yu, Chongli Chen, Chao Liang
  Molecular Biomedicine.2024;[Epub]     CrossRef
• Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
  Kyeong-Ryoon Lee, Aneela Gulnaz, Yoon-Jee Chae
  Pharmaceutics.2024; 16(11): 1431.     CrossRef
• Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss
  Jeremy A. Klein, Joëlle St-Pierre, David Choi, Jacqueline Lopez, David T. Rubin
  ACG Case Reports Journal.2024; 11(11): e01544.     CrossRef
• Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?
  Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai
  International Immunopharmacology.2023; 116: 109597.     CrossRef
• Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression
  Anuraag Jena, Pardhu B Neelam, Harshavardhan Telaprolu, Uday Kiran Mangipudi, Usha Dutta, Shaji Sebastian, Vishal Sharma
  Clinics and Research in Hepatology and Gastroenterology.2023; 47(7): 102155.     CrossRef
• Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study
  Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park
  Gut and Liver.2023; 17(4): 581.     CrossRef
• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review
  Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon
  Reproductive Medicine.2023; 4(3): 180.     CrossRef
• Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
  Rohan V Yewale, Balakrishnan S Ramakrishna, Babu Vinish Doraisamy, Pandurangan Basumani, Jayanthi Venkataraman, Kayalvizhi Jayaraman, Ananthavadivelu Murali, Karunakaran Premkumar, Akkim Sathish Kumar
  JGH Open.2023; 7(9): 599.     CrossRef
• Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
  Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee Cheon
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Oral Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Spore Powder Ameliorates Murine Colitis by Inhibiting Key Kinases Phosphorylation in MAPK Pathway
  Yingying Zhao, Liangchen Zhu
  International Journal of Medicinal Mushrooms.2023; 25(10): 39.     CrossRef
• Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery
  Mehrab Pourmadadi, Arsalan Rahmani Ghohrodi, Zeinab Savari, Ehsan Talebi, Iman Ahamdi, Abbas Rahdar, Sadanand Pandey
  Next Nanotechnology.2023; 2: 100018.     CrossRef
• Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD
  Fiona Yeaman, Amelie Stritzke, Verena Kuret, Nastaran Sharifi, Cynthia H Seow, Amy Metcalfe, Yvette Leung
  Crohn's & Colitis 360.2023;[Epub]     CrossRef
• Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis
  Apurva Jadhav, Suresh Jagtap, Suresh Vyavahare, Archana Sharbidre, Bipinraj Kunchiraman
  Frontiers in Cellular and Infection Microbiology.2023;[Epub]     CrossRef
• Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
  Journal of Personalized Medicine.2022; 12(3): 507.     CrossRef
• Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
  Bipadabhanjan Mallick, Sarthak Malik
  Cureus.2022;[Epub]     CrossRef
• Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?
  Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, Anna Viola
  Drugs & Aging.2022; 39(6): 441.     CrossRef
• Personalized medicine in inflammatory bowel disease: Perspectives on Asia
  Su Hyun Park, Sang Hyoung Park
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
• Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
  Jung-Bin Park, Sang Hyoung Park
  Intestinal Research.2022; 20(3): 279.     CrossRef
• Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
  Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2022; 37(5): 895.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• Vaccination strategies for Korean patients with inflammatory bowel disease
  Yoo Jin Lee, Eun Soo Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
• Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
  Jongwook Yu, Soo Jung Park, Hyung Wook Kim, Yun Jeong Lim, Jihye Park, Jae Myung Cha, Byong Duk Ye, Tae Oh Kim, Hyun-Soo Kim, Hyun Seok Lee, Su Young Jung, Youngdoe Kim, Chang Hwan Choi
  Gut and Liver.2022; 16(5): 764.     CrossRef
• A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients
  Debbie S. Deben, Rob H. Creemers, Arjan J. van Adrichem, Roosmarie Drent, Audrey H. H. Merry, Mathie P. G. Leers, Adriaan A. van Bodegraven, Dennis R. Wong
  Scientific Reports.2022;[Epub]     CrossRef
• Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
  Alexander Keith Turbayne, Miles Patrick Sparrow
  Digestive Diseases and Sciences.2022; 67(12): 5382.     CrossRef
• NUDT15Genotyping in Thiopurine Drug Therapy
  Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
  Laboratory Medicine Online.2022; 12(4): 217.     CrossRef
• Personalized medicine to implementation science: Thiopurines set for the leap
  Vishal Sharma, Saurabh Kedia, Vineet Ahuja
  JGH Open.2022; 6(10): 651.     CrossRef
• Immunomodulators: still having a role?
  Jeffery M Venner, Charles N Bernstein
  Gastroenterology Report.2022;[Epub]     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
  Jin Wook Lee, Eun Soo Kim
  Gut and Liver.2021; 15(5): 639.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef
• Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease
  Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven
  Expert Opinion on Drug Metabolism & Toxicology.2021; 17(12): 1433.     CrossRef